ÄûÃʵ¼º½

News

Graphene nanoribbons - chiral or not?

Fabian's paper on growth of chiral nanoribbons out in J. Phys. Chem. C
text9862_en.png

We show that the precursor geometry controls whether we form regular armchair or chiral graphene nanoribbons (GNRs). On Cu(111), bianthryl precursors (dibromo-, dichloro-, or halogen-free bianthryl) unexpectedly yield chiral GNRs. Using atomically resolved noncontact atomic force microscopy (nc-AFM), we studied the growth mechanism in detail. In contrast to the nonplanar BA-derived precursors, planar dibromoperylene (DBP) molecules do form armchair GNRs by Ullmann coupling on Cu(111), as they do on Au(111). These results highlight the role of the substrate, precursor shape, and molecule–molecule interactions as decisive factors in determining the reaction pathway. Our findings establish a new design paradigm for molecular precursors and opens a route to the realization of previously unattainable covalently bonded nanostructures.

The results are published in

  • Updated:
  • Published:
Share
URL copied!

Read more news

Person in dark suit presenting ELLIS Institute Finland slide with colourful icons in a lecture room
Cooperation, Press releases, Research & Art Published:

ELLIS Institute Finland is launching machine learning fundamentals out of the lab

Research moonshots, foundation models for healthcare, and AI for RDI
Research & Art Published:

ACRIS service restored

The ACRIS research information management system is now open following the planned service break on 13–20 April 2026.
Design Methods class smiling faces during group work. Photo: Ayse Pekdiker
Research & Art Published:

Science must have a voice in society – but how?

Trust in science has fallen in Finland by almost ten percentage points in two years
The Proteins.1 team smiling at the camera. 3 men wearing dark shirts smiling at the camera
Research & Art Published:

Meet our startup: Proteins.1 aims for a breakthrough in early disease detection

Biotechnology startup Proteins.1 is developing a technology that could enable the detection of diseases such as cancer months, or even years, earlier than is currently possible. The key lies in identifying individual proteins from a blood sample.